Quest Diagnostics Incorporated (DGX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Quest Diagnostics Incorporated, updated every trading day.
Health Care · Medical Specialities
Price
$245.62
+1.26% today
Market cap
$26.7B
Overall quality
54/100
Kronos AI 30-day
−9.5%
0 of 8 simulated paths end higher
Quest Diagnostics Incorporated (DGX) is a Health Care company in Medical Specialities, worth $26.7B. It trades at $245.62, up 1.26% today, at 24.1 times earnings. Its overall quality score is 54 out of 100, ranked against the whole US market. 6 analysts' average target of $259.50 implies +5.7% from today's price. Kronos AI's 30-day forecast is −9.5% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $259.50 |
| Low – high | $250.00 – $265.00 |
| Analysts | 6 |
| Upside to average | +5.7% |
Kronos AI 30-day forecast
| Expected close | $219.53 (−9.5%) |
| Likely range | −13.2% … −7.8% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 68 |
| Solvency | 42 |
| Growth | 51 |
| Overall | 54 |
| P/E | 24.1 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Medical Specialities
For information only, not investment advice. Prices updated: 2026-10-29.